Home/Contractors/Emergent Biodefense Operations Lansing LLC

Federal Contractor Profile

Emergent Biodefense Operations Lansing LLC

Federal contracting record: $923M obligated across 19 awards from 3 agencies, FY 2016–2026.

$923M
Total Obligated
19
Award Records
3
Agencies Served
5
NAICS Codes
OverviewContractsAgenciesNAICS

Company Profile

UEI (Unique Entity Identifier)

MUM1EGCDWZJ4

CAGE Code

1H0B6

Parent Organization

Emergent Biosolutions INC.

Address

3500 N MARTIN LUTHER KING JR BLVD, LANSING, MI, 489062933

First Federal Award

Mar 22, 2016

Most Recent Award

Apr 10, 2026

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

  • Department of Health and Human Services

    13 awards · 92.8% of total

    $856M

  • Department of Defense

    4 awards · 5.3% of total

    $49M

  • Department of State

    2 awards · 1.9% of total

    $18M

Top NAICS Activity

  • 325414

    BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

    8 awards

    $747M

  • 541711

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

    2 awards

    $109M

  • 325411

    MEDICINAL AND BOTANICAL MANUFACTURING

    5 awards

    $67M

  • 325412

    PHARMACEUTICAL PREPARATION MANUFACTURING

    2 awards

    $139K

  • 541380

    TESTING LABORATORIES

    1 awards

    $128K

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Apr 10, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412BIO THRAX VACCINE$3K
Jan 8, 2026Department of DefenseW6QK ACC-APG325411FOR THE PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ABSORBED (AVA))$7.2M
Mar 13, 2025Department of DefenseW6QK ACC-APG325411PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)$6.9M
Jan 22, 2025Department of DefenseW6QK ACC-APG325411PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)$6.9M
Dec 11, 2024Department of DefenseW6QK ACC-APG325411PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)$6.9M
Mar 21, 2024Department of DefenseW6QK ACC-APG325411PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)$7.8M
Feb 13, 2024Department of DefenseW6QK ACC-APG325411PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)$6.7M
Jan 19, 2024Department of DefenseW6QK ACC-APG325411PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)$6.5M
Jul 1, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711TAS::75 0140::TAS EMERGENT BIODEFENSE OPERATIONS LANSINGS DEVELOPMENT AND LICENSURE OF A LARGE SCALE MANUFACTURING PROCESS FOR BIOTHRAX$9.2M
Jun 16, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF ANTHRAX VACCINE$12M
May 3, 2022Department of Health and Human ServicesASPR/ORM-SNS325412ANNUAL POTENCY TESTING OF THE WETVAX (APSV) VIALS STORED AT THE SNS.$146K
Apr 13, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF ANTHRAX VACCINE$9.5M
Sep 30, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF ANTHRAX VACCINE$21M
Jan 22, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF ANTHRAX VACCINE$24M
Jan 7, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF ANTHRAX VACCINE$10M
Dec 30, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF ANTHRAX VACCINE$5.0M
Jul 8, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF ANTHRAX VACCINE$28M
Jan 14, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF ANTHRAX VACCINE$145M
Sep 21, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325414IGF::OT::IGF ANTHRAX VACCINE$26M
Aug 30, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES541380IGF:OT:IGF VACCINE POTENCY TESTING$128K
Jun 20, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325414IGF::OT::IGF ANTHRAX VACCINE$301
Jun 19, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325414IGF::OT::IGF ANTHRAX VACCINE$82M
Feb 27, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325414IGF::OT::IGF ANTHRAX VACCINE$26M
Sep 29, 2017Department of StateACQUISITIONS - AQM MOMENTUM325411THE PURPOSE OF THE BASE CONTRACT IS TO ESTABLISH A VEHICLE FOR ORDERING A SERIES OF DRUG FILLED AUTOINJECTORS. THIS DELIVERY ORDER IS TO PROCURE AUTOINJECTOR UNITS WHICH WILL BE SENT TO DOS POSTS WORLDWIDE. IGF::CT::IGF$18M
Sep 20, 2017Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325414IGF::OT::IGF ANTHRAX VACCINE$64M

Related Contractors

Other companies active in NAICS 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING.

Sanofi Vaccines US INC.

$1.2B

Advanced Technology International

$917M

Emergent Product Development Gaithersburg INC.

$276M

Seqirus USA INC

$104M

Seqirus INC

$56M

Valneva USA, INC.

$48M

Modernatx, INC.

$48M

Boehringer Ingelheim Animal Health France

$28M

Track Emergent Biodefense Operations Lansing LLC Recompetes Before They Post

Mindy monitors Emergent Biodefense Operations Lansing LLC's active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts